This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Medigenebio Corporation, The Green Cross Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 264 
Years Active: 2020
Title: **Jin-Kyung Lee: A Pioneer in Hunter Syndrome Therapeutics**
Introduction
Jin-Kyung Lee is an innovative inventor based in Yongin-si, South Korea. He has made significant contributions to the medical field, particularly in the treatment of rare diseases. With one patent to his name, he is recognized for his groundbreaking work in developing therapeutic agents that enhance patient welfare.
Latest Patents
Jin-Kyung Lee's notable patent revolves around a therapeutic agent and treatment method for Hunter syndrome. This innovative agent consists of a first composition intended for intravenous injection and a second composition for subcutaneous injection. Remarkably, this therapeutic approach can reduce the frequency of hospital visits for patients with Hunter syndrome to twice a month or less. Furthermore, it maintains a medicinal effect that is equivalent to or even greater than traditional once-a-week IV injections. This advancement not only increases patient compliance with drug regimens but also significantly enhances the overall welfare and convenience of patients undergoing treatment.
Career Highlights
Throughout his career, Jin-Kyung Lee has been associated with reputable companies in the biotech industry. Notably, he has worked with Green Cross Corporation and Medigenebio Corporation, where he furthered his research and development efforts in therapeutic solutions for complex medical conditions. His commitment to innovation and patient care is evident in his work.
Collaborations
In his pursuit of medical advancements, Jin-Kyung Lee has collaborated with talented professionals in the field, including notable coworkers such as Han-Yeul Byun and Myung-Eun Jung. These collaborations have fostered a dynamic environment for innovation and have contributed to the successful development of therapeutic solutions.
Conclusion
Jin-Kyung Lee stands out as a leading inventor in the field of therapeutic innovations. His dedication to improving treatment methods for Hunter syndrome underscores the importance of inventive solutions in enhancing patient care. As he continues to explore new ideas and collaborations, the impact of his work is sure to resonate within the medical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile